Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page
- Check3 days agoChange DetectedThe page now indicates that recruitment is closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a revision update (v3.6.0) and a formatting tweak to the Intervention/Treatment label.SummaryDifference0.4%

- Check11 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a newer version of the page content has been published. No additional changes are described in the provided data.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, reflecting a refreshed build of the page content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision label in the footer was updated from v3.5.0 to v3.5.3, reflecting a ClinicalTrials.gov site version change rather than any modification to the study record content.SummaryDifference0.0%

- Check89 days agoChange Detected- The page now shows Revision: v3.5.0 and the previous Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check104 days agoChange DetectedRevision note updated from v3.4.2 to v3.4.3 on the site.SummaryDifference0.0%

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.